Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Good Were Celldex Therapeutics' Latest Clinical Results?

TheMotleyFool

0 0

How Good Were Celldex Therapeutics' Latest Clinical Results?

Celldex Therapeutics (NASDAQ: CLDX) recently announced results from a phase 1b clinical study evaluating CDX-0159 in treating two of the most common forms of chronic inducible hives. In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss just how good the biotech's latest clinical results were.

Source Fool.com

Like: 0

CLDX

Share